MULTIVESSEL PCI. IN DRUG-ELUTING STENT RESTENOSIS DUE TO STENT FRACTURE, TREATED WITH REPEAT DES IMPLANTATION

Similar documents
DEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea.

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial

Bifurcation stenting with BVS

Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)?

Radiation Safety Abbott Vascular. All rights reserved.

LM stenting - Cypher

Flexibility of the COMBO Dual Therapy Stent

Αγγειοπλαστική σε Eπαναστενωτικές Bλάβες

Solving the Dilemma of Ostial Stenting: A Case Series Illustrating the Flash Ostial System

FFR-guided Jailed Side Branch Intervention

Patient. Clinical data Indications: Operation date. Comorbidities: Patient code Birth date: / /

Coronary angiography and PCI

Mid-term results from real-world REPARA registry. Felipe Hernandez, on behalf of the REPARA investigators

Technical considerations in the Treatment of Left Main Lesions Ioannis Iakovou, MD, PhD

September Peter Barlis. Royal Brompton Hospital, London, UK

ΑΝΤΙΓΝΩΜΙΕΣ ΣΤΗΝ ΕΠΕΜΒΑΤΙΚΗ ΚΑΡΔΙΟΛΟΓΙΑ:Νόσος στελέχους Αγγειοπλαστική

PCI for Ostial Lesion

PROMUS Element Experience In AMC

EBC London 2013 Provisional SB stenting strategy with kissing balloon with Absorb

For Personal Use. Copyright HMP 2013

Stents selection and optimal implantation: sizes, design, deployment Abbott Vascular. All rights reserved.

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

Kurdistan Technique for the Treatment of Unprotected Trifurcation Left Main Stem Coronary Artery Lesion: Case Report

IN-STENT RESTENOSIS. K.Boerlage-van Dijk CarVasZ 2014

Excimer Laser for Coronary Intervention: Case Study RADIAL APPROACH: CORONARY LASER ATHERECTOMY FOR CTO OF THE LAD FOLLOWED BY PTCA NO STENTING

Cardiologic history. Anamnesis. Female BD Risk factors HTN, DM, Dyslipidaemia. Cardiologic Long history. Last admission Heart failure

Coronary Artery Perforation Angioplasty Summit Seoul April 30, 2005

Sirolimus-Eluting Stents for Treatment of In-Stent Restenosis

Percutaneous coronary intervention of RIMA. The real challenge!

Αγγειοπλαστική σε Nόσο Στελέχους: Που βρισκόμαστε. Βάιος Τζίφος Δ/ντής Τμήματος Επεμβατικής Καρδιολογίας Τομέας Καρδιάς Ερρίκος Ντυνάν Hospital Center

TCTAP Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI

Bifurcation Stenting: IVUS and OCT Information

Stent Fracture and Longitudinal Compression on CT Angiography between the

Ruofei Jia, Zening Jin, Hong Li, Jing Han. Introduction

ΣΥΜΠΛΟΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΕΣ ΑΓΓΕΙΟΠΛΑΣΤΙΚΗ ΔΙΧΑΣΜΩΝ

PCI for In-Stent Restenosis. CardioVascular Research Foundation

Debate Should we use FFR? I will say NO.

Le# main treatment with Stentys stent. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy

When Aspiration Thrombectomy Does Not Work? A A R O N W O N G N A T I O N A L H E A R T C E N T R E S I N G A P O R E

FLEXIBLE, BALOON EXPANDABLE

Management of Non-protected Left-Main Bifurcation without Drug Eluting Stent. Masahiko Ochiai MD, FACC, FESC, FSCAI

Why I try to avoid side branch dilatation

Unprotected LM intervention

Final Clinical and Angiographic Results From a Nationwide Registry of FIREBIRD Sirolimus- Eluting Stent: Firebird In China (FIC) Registry (PI R. Gao)

Analysis of macrophage accumulation using optical coherence tomography one year after sirolimus, paclitaxel and zotarolimus-eluting stent

STEMI ST Elevation Myocardial Infarction

Supplementary Material to Mayer et al. A comparative cohort study on personalised

TLR des Stents Actifs

Biodegradable Stents An update and work-in

CASE from South Korea

Are Asian Patients Different? - Updates Of Biomatrix Experience In Regional Settings: BEACON II (3 Yr F up) &

Intravascular Ultrasound for Complex Cases

Coronary artery Dissection. Dr TP Singh MD,DM

Evolution In Interventional Cardiology. Jawed Polad Jeroen Bosch Hospital s-hertogenbosch The Netherlands

Incidence and predictors of drug-eluting stent fractures in long coronary disease

Pathology of Cardiovascular Interventions. Body and Disease 2011

ReZolve2 Bioresorbable Coronary Scaffold Clinical Program Update

Medtronic Symposium The Complex Bifurcation Patient: new insights into stent selection

PCI for Left Anterior Descending Artery Ostial Stenosis

PCI for Long Coronary Lesion

A52-year-old woman with hypertension, dyslipidemia,

in an Unyielding Patient Dr Jason See, Dr Goh Yew Seong, Dr Rohit Khurana Changi General Hospital Singapore

Abstract Background: Methods: Results: Conclusions:

In-Stent Restenosis. Can we kill it?

Longitudinal stent distortion in clinical practice. How common is the problem and does stent design matter?

PCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France

The 3 top Messages from technique Specific problems Solving

ANGIOPLASY SUMMIT 2007 TCT ASIA PACIFIC. Seoul, Korea: April Session: Left mains & bifurcation intervention

Basics of Angiographic Interpretation Analysis of Angiography

Case Report Primary Percutaneous Coronary Intervention in an Acute Myocardial Infarction Due to the Occlusion of the Left Main Coronary Artery

2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium. Seoul National University Hospital Cardiovascular Center

stent (stent fracture) clopidogrel in stent restenosis drug eluting stent(des) (overlap) mail:

Side Branch Occlusion

Technical Characteristics of coronary prostheses(stents)

Longitudinal distortion of coronary stent in the Left Main Stem: A cautionary tale

2017 Cardiology Survival Guide

The MAIN-COMPARE Study

Antonio Colombo. Centro Cuore Columbus and S. Raffaele Scientific Institute, Milan, Italy. Miracor Symposium. Speaker: 15. Parigi: May 16-19, 2017

Very delayed coronary stent fracture presenting as unstable angina: A case report

J Am Coll Cardiol 1995; 25: 1479

Department of Internal Medicine, Saitama Citizens Medical Center, Saitama , Japan

Modified Flower Petal Technique

DESolve NX Trial Clinical and Imaging Results

True Bifurcation LM Stenosis (Medina 1,1,1) With Very Extensive Calcification: CABG Or PCI?

Current DES designs and expansion capacity testing

LCX. President / Director of Cardiology / New Tokyo Hospital

Pathology of percutaneous interventions (PCI) in coronary arteries. Allard van der Wal, MD.PhD; Pathologie AMC, Amsterdam, NL

Bifurcations Bad Krozingen I

Polymer-Free Stent CX - ISAR

PCI TO CHRONIC TOTAL OCCLUSION, LIAQUAT NATIONAL HOSPITAL EXPERINCE

Case Report A Rare Case of Complete Stent Fracture, Coronary Arterial Transection, and Pseudoaneurysm Formation Induced by Repeated Stenting

Chronic Total Occlusions. Stephen Cook, MD Medical Director, Cardiac Catheterization Laboratory Oregon Heart & Vascular Institute

Drug eluting balloons in CAD

STENTYS for Le, Main Sten2ng. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy

Coronary stenting: the appropriate use of FFR

Non-LM bifurcation studies of importance in 2011

Interventional Cardiology חיים דננברג מערך הלב

Bench test : Is it still useful? Do we need standardization?

A Case of Recoiling of Everolimus - eluting Stent at the Ostium of the Right Coronary Artery by Out - stent Plaque Progression

CAROTID ARTERY ANGIOPLASTY

Transcription:

MULTIVESSEL PCI. IN DRUG-ELUTING STENT RESTENOSIS DUE TO STENT FRACTURE, TREATED WITH REPEAT DES IMPLANTATION C. Graidis, D. Dimitriadis, A. Ntatsios, V. Karasavvides Euromedica Kyanous Stavros, Thessaloniki. AICT 2010-Athens Interventional Cardiovascular Therapeutics XI 8-9 OCTOBER 2010 Divani Caravel Hotel, Αthens

Criteria for case selection: DES Restenosis - Stent Fracture IVUS Venture catheter Rotablator Bifurcation Dissection

CASE REPORT 73 y.o. female patient, presenting with crescendo angina. Risk factors for IHD: Dyslipidaemia Hypertension No other significant past medical history Physical examination unremarkable Normal ECG

2007 Significant proximal LAD disease Taxus 2.75x32mm

5/2009: recurrent angina of recent onset progression of the disease with severe lesion in the mid segment of the LAD and no restenosis in the previously implanted stent.

5/2009: PCI - LAD PROMUS 2.5x28mm Jailed guidewire in D1 PROMUS 2.75x18mm Postdilatation

5/2009: PCI - LAD FINAL RESULT Stent length 46mm

5/2009 Severe lesion in the intermediate branch and the circumflex artery.

5/2009: PCI-INTERMEDIATE BRANCH Promus 2.5x12mm DISSECTION!!!!

5/2009: PCI-INTERMEDIATE BRANCH RESIDUAL DISSECTION Promus 2.25x15mm

5/2009: PCI-INTERMEDIATE BRANCH Promus 2.25x15mm

5/2009: PCI-INTERMEDIATE BRANCH FINAL RESULT Promus 2.5x12mm, 2.25x15mm, 2,25x15mm

12/2009: recurrent chest pain!!! Severe stenosis of the intermediate branch within the stented segment, with stent strut fracture near the distal overlapping site.

E D C B A

12/2009 Significant hyperplasia and absence of the metallic stent struts corresponding to complete fracture of the distal stent.

FINAL RESULT 12/2009 Promus Element 2.25x16 mm

12/2009: PCI-Cx Promus Element 2.25x12mm Due to severe tortuosity of the proximal segment of the Cx, the Venture wire control catheter was used, in order to facilitate the passage of the guide-wire.

Venture Wire Control Catheter

12/2009: PCI-RCA RCA severely calcified with angulation at its proximal segment. Significant stenosis at the bifurcation with an acute marginal branch.

12/2009 Due to inability to advance a balloon, decision was made to rotablate. (RA burr size 1.5mm)

12/2009: PCI-RCA Promus Element 3.0x18mm Kissing balloon

12/2009: PCI-RCA FINAL RESULT

FOLLOW-UP ANGIOGRAPHY (9 MONTHS)

FOLLOW-UP ANGIOGRAPHY (9 MONTHS)

FOLLOW-UP ANGIOGRAPHY (9 MONTHS)

Coronary stent fracture is a rare but potentially serious complication The reported incidence of SF in different studies ranges between 0.8% and 7.7%, mainly due to variations - in the rates of angiographic follow-up - use of IVUS - definition of stent fracture and - differences in the types of stents used IVUS was more sensitive than fluoroscopy in detecting stent strut fractures in multiple studies Since IVUS evaluation is not routinely performed during follow-up, stent fracture is likely to be underdiagnosed

Factors predisposing to (drug-eluting) Stent Fracture Anatomic Procedural Stent design Cardiac motion Long stent Closed cell Vessel angulation Right coronary artery Saphenous vein graft Overlapping stent High pressure Overexpansion

The change in vessel angulation after stent implantation is also associated with the occurrence of SF. Stent placement often straightens out the vessel; however, the vessel continues to return to its original shape. The force to return the vessel to its original shape may be stronger if the change in vessel angulation after stent implantation is increased. Longer stents are subjected to higher radial forces compared to shorter ones, and they may be prone to fracture, especially when placed in tortuous vessels or calcified lesions.

Most studies reported overlapping stents as a significant risk factor for SF, with an average rate of over 60% associated with overlapping stented lesions The majority of stent fractures occurred within 10 mm from areas of increased rigidity caused by strut overlap.

The majority of DES fracture events have been reported in SESs The closed-cell design of SES may be more prone to fracture when sheer forces are beyond its flexibility. The closed-cell design of the Cypher stent is more rigid, resulting in more straightening of coronary vessels compared to the open cell Taxus design. However, it also must be taken into account that the Cypher stent is more radio-opaque and stent fracture may be easier to diagnose by angiography.

Stent fractures were more commonly reported in the RCA. The predisposition of the RCA for SF is possibly attributed to the vessel anatomy, due to the excessive tortuosity, angulation, or change of angulation after stent implantation. The next most common locations were the LAD, Cx, saphenous vein grafts and the left main stem.

Clinical Implications The complications observed with DES fracture include : in-stent restenosis and target lesion revascularization, stent thrombosis myocardial infarction and sudden death Patients may remain asymptomatic

While most of the stent fractures have been discovered during follow-up angiography six months or more post-implantation, SF cases have been reported from immediately after to several years after the index procedure The length of time that a vessel wall is exposed to fractured stent struts may be important and possibly determine clinical outcomes. An early fracture affects local drug delivery and can lead to focal neointimal hyperplasia. On the other hand, since significant restenosis was not observed in a significant number of fracture sites, it may be presumed that in these cases, stent strut fracture occurred long enough after implantation so that the drug effect was not compromised.

Management strategies The management of stent fractures remains controversial. If focal in-stent restenosis occurs, it seems reasonable to repeat percutaneous revascularisation with a short stent. With repeat stenting there is a possibility of recurrence of SF whereas, on the other hand, the effect of balloon angioplasty on disrupted DESs is unknown. The use of paclitaxel-eluting stents or other newly developed DESs might be an appropriate selection since their platform is more flexible.

In our case, it seems that the use of three, overlapping stents along with the presence of angulation and increased vessel movememt contributed to the fracture. Despite the fact that each of them had relatively short length, the fracture occurred very close to the distal overlapping site, at a point where there was a vessel angulation. Point of distal overlapping

A careful examination of the vessel anatomy, careful selection of the stent length and type and a proper deployment technique is required for special coronary situations in order to reduce the occurrence of this phenomenon.

ΕΥΧΑΡΙΣΤΩ!